Federal contractor · public award history
AMGEN USA INC
Parent: AMGEN USA INC Unique Entity Identifier (UEI)Y6NEW42XK544
- Awards we know about
- 7
- Typical size
- $811,924
- Middle of their public awards
- Dollars on those awards
- $714.77M
Most of their awards we can see fall roughly between $438,701 and $357.35M.
SAM.gov registration
- Status
- Active
- Purpose of registration
- All awards (Z2)
- Registration expires
- Mar 19, 2027
- Activation date
- Mar 19, 2026
- Primary NAICS (SAM)
- Pharmaceutical Preparation Manufacturing325412
Other NAICS on file
Business types (SAM)
Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.
Continue contractor research
Use the verified identifiers and public award record to investigate documented incumbents, compare competitors, or identify possible teaming partners. This is a research starting point, not a capability or partner recommendation.
These official USAspending contract records do not rate capability or past performance and do not tell you whether to team or bid.
Awarding agencies
- Department of Veterans Affairs (5)
- Department of Health and Human Services (2)
Industries & product codes
Award history
- Department of Veterans Affairs—Sep 30, 2025Procurement Instrument Identifier (PIID)36F79721D0086Pharmaceutical Preparation Manufacturing325412Drugs And Biologicals6505Indefinite Delivery Vehicle (IDV)USAspending ↗
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
- Department of Veterans Affairs—Sep 2, 2025Procurement Instrument Identifier (PIID)36E79725D0053Pharmaceutical Preparation Manufacturing325412Drugs And Biologicals6505Indefinite Delivery Vehicle (IDV)USAspending ↗
NEW AWARD FOR TRASTUZUMAB WITH AMGEN. ORDERING PERIOD IS NOV 15, 2025 THROUGH NOV 14, 2026 WITH FOUR ONE-YEAR OPTIONS.
- Department of Health and Human Services$713.89MJul 15, 2025Procurement Instrument Identifier (PIID)75A50122C00065Research and Development in Biotechnology (except Nanobiotechnology)541714Health R&D Services; Health Care Services; Experimental DevelopmentAN13Contract awardUSAspending ↗
TREATMENT FOR USE IN A MASS CASUALTY EVENT WHERE THROMBOCYTOPENIA OR PLATELET LOSS IS A MAJOR CONCERN.
- Department of Health and Human Services$811,924Jun 5, 2025Procurement Instrument Identifier (PIID)75A50124C00011Research and Development in Biotechnology (except Nanobiotechnology)541714Health R&D Services; Health Care Services; Experimental DevelopmentAN13Contract awardUSAspending ↗
VENDOR MANAGED INVENTORY (VMI) SERVICES FOR USG PROCURED 165,906 DOSES OF NEULASTA PRODUCT TO MITIGATE INJURIES CAUSED BY EXPOSURE TO CHEMICAL, BIOLOGICAL THREAT AGENTS, PHYSICAL, RADIOLOGIC AND NUCLEAR EXPOSURES.
- Department of Veterans Affairs—Jan 13, 2025Procurement Instrument Identifier (PIID)36E79725D0009Pharmaceutical Preparation Manufacturing325412Drugs And Biologicals6505Indefinite Delivery Vehicle (IDV)USAspending ↗
2 LINE ITEMS CALCITONIN GENE-RELATED PEPTIDES (CGRP) AWARDED FOR A BASE YEAR PERIOD OF 2/26/2025 TO 2/25/2026 PLUS FOUR ONE-YEAR OPTION PERIODS.
- Department of Veterans Affairs—Dec 12, 2024Procurement Instrument Identifier (PIID)36E79720D0006Pharmaceutical Preparation Manufacturing325412Drugs And Biologicals6505Indefinite Delivery Vehicle (IDV)USAspending ↗
ERENUMAB-AOOE 70MG/ML AUTOINJECTOR 1ML ERENUMAB-AOOE 140MG/ML AUTOINJECTOR 1ML
- Department of Veterans Affairs$65,478Oct 4, 2024Procurement Instrument Identifier (PIID)36C26024F0036Pharmaceutical Preparation Manufacturing325412Drugs And Biologicals6505Contract awardUSAspending ↗
TAVNEOS (AVACOPAN)
For research only. This is not legal advice, a past-performance review, or a recommendation to team or bid. Check USAspending and SAM.gov.